Long-term suppression maintained after cessation of AB-729 treatment and comparable on-treatment response observed in HBeAg plus subjects

Yuen, MF; Berliba, E; Sukeepaisarnjaroen, W; Holmes, J; Leerapun, A; Tangkijvanich, P; Strasser, S; Jucov, A; Gane, EJ; Thi, EP; Sevinsky, H; Medvedeva, E; Sharma, V; Gray, K; Antoniello, D; Picchio, G; Sims, K; Eley, T

JOURNAL OF HEPATOLOGY, 2022; 77 (): S876